Table 2.

Incidence of LAIPs in AML

Leukemic phenotype	Incidence	Examples
Asynchronous expression	60–70%	CD34 CD14 CD117 CD15
Cross-lineage expression	30–40%	CD19 CD2 CD7
Overexpression	20–30%	CD34 CD13 CD33 CD64 CD15 CD14
Lack of expression	20–30%	DR CD33 CD13
Overall	90–95%